PMID: 9631577Jun 19, 1998Paper

Biological activities and clinical application of M-CSF

International Journal of Hematology
K Motoyoshi

Abstract

Macrophage colony-stimulating factor (M-CSF) was found to be a glycoprotein with a molecular weight of 85 kDa which stimulated macrophage colony formation of mouse bone marrow cells in a semisolid agar culture system in 1978. M-CSF stimulates differentiation of progenitor cells to mature monocytes, and prolongs the survival of monocytes. It enhances expression of differentiation antigens and stimulates chemotactic, phagocytic and the killing activities of monocytes. Macrophage CSF also stimulates production of several cytokines such as granulocyte-macrophage CSF, granulocyte CSF and interleukin (IL)-6 by priming monocytes, and directly stimulates production and secretion of IL-8 and reactive nitrogen intermediates. In addition to the stimulation of hematopoiesis, M-CSF also stimulates differentiation and proliferation of osteoclast progenitor cells and cytotrophoblasts. Proteoglycan type M-CSF, which contains chondroitin sulfate chains, was found in 1992. In a large-scale double-blind controlled study on acute myeloid leukemia (AML), it has been shown that the administration of M-CSF to patients after consolidation chemotherapies shortens the periods of neutropenia and thrombopenia after chemotherapy and reduces the incidence a...Continue Reading

Citations

May 10, 2001·International Journal of Hematology·S SuzuK Motoyoshi
May 20, 2003·British Journal of Haematology·Kraig AbramsRichard A Nash
Feb 15, 2012·Laboratory Investigation; a Journal of Technical Methods and Pathology·Richard Mi TaylorNicholas A Athanasou
Dec 31, 2004·Immunological Investigations·Daisuke TsuchimotoShigetaka Asano
Mar 14, 2007·The Journal of Biological Chemistry·Benjamin PakutsC Jane McGlade
Jul 26, 2002·International Journal of Hematology·Kiyoko S Akagawa
Jul 26, 2002·International Journal of Hematology·Shinya Suzu, Kazuo Motoyoshi
Aug 5, 2003·International Journal of Hematology·Zhen-Yu CaoKe-Fu Wu
Sep 11, 2007·The Journal of Biological Chemistry·Patrick C HaningtonMiodrag Belosevic
Jan 21, 2006·Respirology : Official Journal of the Asian Pacific Society of Respirology·Kiyoko S AkagawaFumio Kishi
Jun 28, 2011·The Journal of Pathology·Richard TaylorNicholas A Athanasou
Nov 19, 2015·Clinical Reviews in Allergy & Immunology·A SabokbarN A Athanasou
Apr 1, 2004·American Journal of Hematology·Hirohito SuzukiHiroshi Shiku
Mar 14, 2009·Nature Reviews. Immunology·Jeffrey W Pollard
Aug 7, 2002·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Takuma SakuraiKazuo Motoyoshi
Feb 28, 2006·Journal of Periodontal Research·Y HaradaM A Taubman
Jan 11, 2002·Developmental Biology·J F RawlsS L Johnson
Dec 13, 2005·Current Opinion in Immunology·Violeta Chitu, E Richard Stanley
Jun 7, 2005·Fish & Shellfish Immunology·Miodrag BelosevicDaniel R Barreda
Dec 10, 2008·Developmental and Comparative Immunology·Patrick C HaningtonMiodrag Belosevic
Sep 6, 2011·Trends in Molecular Medicine·James A StefaterJeremy S Duffield

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.